Different IVIG glycoforms affect in vitro inhibition of anti-ganglioside antibody-mediated complement deposition

PLoS ONE

Volumn 9, Issue 9, 2014, Pages

  Sudo, Makoto ^a   Yamaguchi, Yoshiki ^b   Späth, Peter J ^c   Matsumoto Morita, Kana ^b   Ong, Benjamin K ^a   Shahrizaila, Nortina ^d   Yuki, Nobuhiro ^a,e  

^a Dept Medicine Endocrinol Diabet   (Singapore)

^b RIKEN   (Japan)

^c UNIVERSITY OF BERN   (Switzerland)

^d UNIVERSITY OF MALAYA   (Malaysia)

^e NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C3; GANGLIOSIDE ANTIBODY; GANGLIOSIDE GM1 ANTIBODY; GANGLIOSIDE GQ 1B ANTIBODY; GLYCOSIDASE; GLYCOSYLTRANSFERASE; IMMUNOGLOBULIN; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; AUTOANTIBODY; COMPLEMENT; GANGLIOSIDE; IMMUNOGLOBULIN G; POLYSACCHARIDE;

ANTIBODY MEDIATED DEPENDENT COMPLEMENT DEPENDENT CYTOTOXICITY; ARTICLE; CHEMICAL MODIFICATION; COMPLEMENT DEPENDENT CYTOTOXICITY; COMPLEMENT DEPOSITION; CONTROLLED STUDY; DEGALACTOSYLATION; DEGLYCOSYLATION; GALACTOSYLATION; GUILLAIN BARRE SYNDROME; HUMAN; MOTOR NEUROPATHY; SIALYLATION; STRUCTURE ANALYSIS; ANTAGONISTS AND INHIBITORS; GLYCOSYLATION; IMMUNOLOGY; IN VITRO STUDY; METABOLISM;

AUTOANTIBODIES; COMPLEMENT SYSTEM PROTEINS; GANGLIOSIDES; GLYCOSYLATION; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULINS, INTRAVENOUS; IN VITRO TECHNIQUES; POLYSACCHARIDES;

EID: 84907909049     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0107772     Document Type: Article

References (15)

1. Kaveri SV, Lacroix-Desmazes S, Bayry J (2008) The Antiinflammatory IgG. N Engl J Med 359: 307-309.
2. Arnold JN, Wormald MR, Sim RB, Rudd PM, Dwek RA (2007) The Impact of Glycosylation on the Biological Function and Structure of Human Immunoglobulins. Annu Rev Immunol 25: 21-50.
3. Yuki N, Hartung HP (2012) Guillain-Barré syndrome. N Engl J Med 366: 2294-2304.
4. Vlam L, van der Pol WL, Cats EA, Straver DC, Piepers S, et al. (2011) Multifocal motor neuropathy: diagnosis, pathogenesis and treatment strategies. Nat Rev Neurol 8: 48-58.
5. Yuki N, Watanabe H, Nakajima T, Späth PJ (2011) IVIG blocks complement deposition mediated by anti-GM1 antibodies in multifocal motor neuropathy. J Neurol Neurosurg Psychiatry 82: 87-91.
6. Piepers S, Jansen MD, Cats EA, van Sorge NM, van den Berg LH, et al. (2010) IVIg inhibits classical pathway activity and anti-GM1 IgM-mediated complement deposition in MMN. J Neuroimmunol 229: 256-262.
7. Jacobs BC, O'Hanlon GM, Bullens RW, Veitch J, Plomp JJ, et al. (2003) Immunoglobulins inhibit pathophysiological effects of anti-GQ1b-positive sera at motor nerve terminals through inhibition of antibody binding. Brain 126: 2220-2234.
8. Zhang G, Lopez PH, Li CY, Mehta NR, Griffin JW, et al. (2004) Anti-ganglioside antibody-mediated neuronal cytotoxicity and its protection by intravenous immunoglobulin: implications for immune neuropathies. Brain 127: 1085-1100.
9. Kaneko Y, Nimmerjahn F, Ravetch JV (2006) Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation. Science 313: 670-673.
10. Nakagawa H, Kawamura Y, Kato K, Shimada I, Arata Y, et al. (1995) Identification of neutral and sialyl N-linked oligosaccharide structures from human serum glycoproteins using three kinds of high-performance liquid chromatography. Anal Biochem 226: 130-138.
11. Takahashi N, Nakagawa H, Fujikawa K, Kawamura Y, Tomiya N (1995) Three-dimensional elution mapping of pyridylaminated N-linked neutral and sialyl oligosaccharides. Anal Biochem 226: 139-146.
12. Takahashi N, Kato K (2003) GALAXY (Glycoanalysis by the three axes of MS and chromatography): a web application that assists structural analyses of N-glycans. Trend Glycosci Glycotechnol 15: 235-252.
13. Holland M, Yagi H, Takahashi N, Kato K, Savage CO, et al. (2006) Differential glycosylation of polyclonal IgG, IgG-Fc and IgG-Fab isolated from the sera of patients with ANCA-associated systemic vasculitis. Biochim Biophys Acta 1760: 669-677.
14. Samuelsson A, Towers TL, Ravetch JV (2001) Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor. Science 291: 484-486.
15. von Gunten S, Shoenfeld Y, Blank M, Branch DR, Vassilev T, et al. (2014) IVIG pluripotency and the concept of Fc-sialylation: challenges to the scientist. Nat Rev Immunol 14: 349.